Description:

Indications and cautions have been updated in line with the revised ACS guideline. GTN is not routinely recommended as first-line therapy in STEMI, but may be used cautiously for symptom relief or to reduce preload if pulmonary oedema or hypertension is present.

Date Update Posted Online: December 10, 2025

Search Updates

The JRCALC logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.